Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Tonix Pharmaceuticals, Inc.

Clinical trials sponsored by Tonix Pharmaceuticals, Inc., explained in plain language.

Tonix Pharmaceuticals, Inc. TNXP NASDAQ

A biopharmaceutical company developing therapies for central nervous system disorders and other conditions.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1 Completed 2

Could a muscle relaxant lift depression? new trial underway

Symptom relief Recruiting now

This Phase 2 trial tests whether TNX-102 SL, a tablet taken under the tongue at bedtime, can improve depression symptoms in adults with moderate to severe major depressive disorder. About 360 participants will receive either the drug or a placebo nightly for 6 weeks. Researchers …

Phase: PHASE2 • Sponsor: Tonix Pharmaceuticals, Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 13:01 UTC